Subscribe

Interpace Biosciences, Inc. (IDXG)

USD1.62 +0.12 (+8.00%)
US OTC Healthcare Medical - Diagnostics & Research
Address Morris Corporate Center 1 7054
Parsippany, NJ, US
CEO Thomas W. Burnell
IPO 1998-05-20
CIK 1054102 ISIN US46062X3035

Explore sections of this company profile

Description

Interpace Biosciences, Inc. is a U.S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system. This test, powered by the proprietary PathFinderTG platform, assists medical professionals in more accurately determining the risk of pancreaticobiliary cancers. It also offers PanDNA, a molecular-only variant of PancraGEN, which delivers insights into a select number of diagnostic markers. For thyroid health, the company provides ThyGeNEXT, an oncogenic mutation panel designed to identify malignant thyroid nodules. Additionally, ThyraMIR evaluates thyroid nodules for malignancy risk through the application of its proprietary microRNA gene-expression assay. Furthermore, RespriDx is a genomic diagnostic tool that aids clinicians in distinguishing between metastatic and recurrent lung cancer. Interpace Biosciences further supports the pharmaceutical and biotechnology sectors with services including pharmacogenomics testing, genotyping, biorepository solutions, and various custom scientific offerings. Its clientele primarily consists of physicians, hospitals, and clinics. Previously operating as Interpace Diagnostics Group, Inc., the company adopted its current name, Interpace Biosciences, Inc., in November 2019. Founded in 1986, its corporate headquarters are located in Parsippany, New Jersey.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD1.62 +0.12 (+8.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6.6K
Beta
0.58
Float Shares
3.47M
Free Float %
78.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-4.00% -4.00% -12.73% +3.78% +97.94% +56.10% +137.04% -23.20% -76.00% -93.60% -99.91%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (7 ratings, all time) Buy
Price Targets & DCF
Current price
1.62
DCF (Unlevered) 1.19 -26.3%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2024-11 Change
Strong Buy 0 0
Buy 1 0
Hold 0 -1
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-6.67
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Diagnostics & Research: +7.9%
    -17.5% Q1'26: -21.6% (vs Q1'25)
  • EPS growth Medical - Diagnostics & Research: +30.8%
    +122.5% Q1'26: -50.0% (vs Q1'25)
  • FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%
    +69.0% Q1'26: +1.6% (vs Q1'25)
  • EBIT margin Medical - Diagnostics & Research: +9.6%
    +10.2% Q1'26: +0.0% (vs Q1'25)
  • ROIC Medical - Diagnostics & Research: +5.2%
    +18.7% Q1'26: +0.0% (vs Q1'25)
  • Share dilution Medical - Diagnostics & Research: 0.0%
    +531.3% Q1'26: +531.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×
    0.25× Q1'26: 0.14× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.65) × ERP
WACC = 98% × Ke + 2% × Kd (14.2%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 1.19 Current price: 1.62
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 1999
actual
Dec 2000
actual
Dec 2001
actual
Dec 2002
actual
Dec 2013
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Revenue
174.90M
est: 156.14M (+12.0%)
416.88M
est: 359.89M (+15.8%)
696.58M
est: 1.59B (-56.1%)
284.01M
est: 227.48M (+24.9%)
150.84M
est: 153.00M (-1.4%)
9.43M
est: 140.17M (-93.3%)
13.09M
est: 156.86M (-91.7%)
15.90M
est: 15.64M (+1.6%)
21.90M
est: 21.89M (+0.0%)
24.08M
est: 30.66M (-21.5%)
32.40M
est: 32.25M (+0.4%)
41.31M
est: 41.96M (-1.5%)
31.84M
est: 46.90M (-32.1%)
40.21M
est: 54.50M (-26.2%)
46.93M
est: 121.68M (-61.4%)
38.73M
est: 38.73M (+0.0%)
EBITDA
16.90M
est: 15.82M (+6.8%)
42.95M
est: 39.48M (+8.8%)
17.70M
est: 61.89M (-71.4%)
-39.59M
est: -66.91M (+40.8%)
-212.0K
est: 2.46M (-108.6%)
-35.47M
est: -12.62M (-181.0%)
-2.16M
est: -14.12M (+84.7%)
-9.01M
est: -1.41M (-539.7%)
-8.57M
est: -1.97M (-334.8%)
-21.72M
est: -2.76M (-686.6%)
-20.10M
est: -2.90M (-592.0%)
-1.33M
est: -3.78M (+64.9%)
-2.27M
est: -6.94M (+67.3%)
3.84M
est: -7.00M (+154.8%)
8.36M
est: 7.13M (+17.2%)
4.76M
est: 2.27M (+109.8%)
EBIT
15.70M
est: 14.15M (+11.0%)
40.88M
est: 33.70M (+21.3%)
12.71M
est: 56.01M (-77.3%)
-46.96M
est: -84.73M (+44.6%)
-1.50M
est: 646.1K (-331.6%)
-40.50M
est: -24.44M (-65.7%)
-6.43M
est: -27.35M (+76.5%)
-12.70M
est: -2.73M (-365.6%)
-12.37M
est: -3.82M (-224.1%)
-26.24M
est: -5.35M (-390.8%)
-25.60M
est: -5.62M (-355.1%)
-6.70M
est: -7.32M (+8.4%)
-4.83M
est: -9.67M (+50.1%)
2.81M
est: -9.94M (+128.3%)
7.61M
est: 486.1K (+1,465.4%)
3.94M
est: 154.7K (+2,448.1%)
Net Income
10.40M
est: 8.39M (+23.9%)
27.03M
est: 22.28M (+21.3%)
6.35M
est: 22.36M (-71.6%)
-30.76M
est: -51.81M (+40.6%)
-4.57M
est: 80.0K (-5,807.7%)
-11.36M
est: -605.41M (+98.1%)
-8.33M
est: -307.09M (+97.3%)
-12.22M
est: -21.06M (+42.0%)
-12.19M
est: -14.04M (+13.2%)
-26.64M
est: -17.03M (-56.4%)
-26.20M
est: -29.04M (+9.8%)
-14.75M
est: -11.45M (-28.8%)
-5.87M
est: -9.71M (+39.6%)
802.0K
est: -10.07M (+108.0%)
6.70M
24.58M
SGA
29.10M
est: 23.37M (+24.5%)
71.65M
est: 60.37M (+18.7%)
123.08M
est: 186.72M (-34.1%)
76.83M
est: 163.80M (-53.1%)
28.69M
est: 42.84M (-33.0%)
27.28M
est: 86.07M (-68.3%)
15.97M
est: 96.32M (-83.4%)
15.72M
est: 9.60M (+63.7%)
16.92M
est: 13.44M (+25.9%)
25.66M
est: 18.83M (+36.3%)
30.02M
est: 19.81M (+51.6%)
23.74M
est: 25.77M (-7.9%)
20.10M
est: 19.20M (+4.7%)
19.60M
est: 20.65M (-5.1%)
21.14M
est: 64.36M (-67.2%)
19.40M
est: 20.48M (-5.3%)
EPS
8.70
est: 71.86 (-87.9%)
20.00
est: 139.52 (-85.7%)
4.60
est: -83.60 (+105.5%)
-21.92
est: -79.81 (+72.5%)
-3.10
est: -79.93 (+96.1%)
-13.70
est: -138.00 (+90.1%)
-10.05
est: -70.00 (+85.6%)
-7.77
est: -4.80 (-61.9%)
-4.33
est: -3.20 (-35.3%)
-7.11
est: -3.88 (-83.1%)
-6.50
est: -6.62 (+1.8%)
-3.57
est: -2.61 (-36.8%)
-1.38
est: -1.37 (-0.7%)
0.19
est: -0.15 (+226.7%)
1.42
5.55
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 A 4/5 1/5 5/5 5/5 3/5 3/5 5/5
2026-05-08 A 4/5 1/5 5/5 5/5 3/5 4/5 5/5
2026-05-07 A 4/5 1/5 5/5 5/5 3/5 4/5 5/5
2026-05-06 A 4/5 1/5 5/5 5/5 3/5 4/5 5/5
2026-05-05 A 4/5 1/5 5/5 5/5 3/5 4/5 5/5
2026-05-04 A 4/5 1/5 5/5 5/5 3/5 4/5 5/5
2026-05-01 A 4/5 1/5 5/5 5/5 3/5 4/5 5/5
2026-04-30 A 4/5 1/5 5/5 5/5 3/5 4/5 5/5
2026-04-29 A 4/5 1/5 5/5 5/5 2/5 4/5 5/5
2026-04-27 A 4/5 1/5 5/5 5/5 2/5 4/5 5/5
2026-04-24 A 4/5 1/5 5/5 5/5 2/5 4/5 5/5
2026-04-23 A 4/5 1/5 5/5 5/5 2/5 4/5 5/5
2026-04-22 A 4/5 1/5 5/5 5/5 2/5 4/5 5/5
2026-04-21 A 4/5 1/5 5/5 5/5 2/5 4/5 5/5
2026-04-20 A 4/5 1/5 5/5 5/5 2/5 4/5 5/5
2026-04-17 A- 4/5 1/5 5/5 5/5 2/5 3/5 5/5
2026-04-16 A- 4/5 1/5 5/5 5/5 2/5 3/5 5/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
4.06M
OE per share TTM
0.39
Owner's Yield
44.35%
Maintenance CapEx ratio
2.52%
Maint CapEx / Avg PPE
17.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
21
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 AMP-18 MC LLC 4.67M 39.10% 4.67M 4.67M IA 2021-05-18
2 AMP-18 Management Company Limited Partnership 4.67M 39.10% 4.67M 4.67M IA 2021-05-18
3 AMP-18 4.67M 38.90% 4.67M 4.67M IA 2021-11-12
4 Ampersand 2018 Limited Partnership 4.67M 38.90% 4.67M 4.67M IV 2021-11-12
5 Limited Partnership 4.67M 3.00% 4.67M 4.67M IA Delaware 2020-04-23
6 Partnership 4.67M 3.00% 4.67M 4.67M IV Delaware 2020-04-23
7 Capital II, L.P. 3.17M 26.40% 3.17M 3.17M PN Delaware 2021-11-12
8 Capital Management II, LLC 3.17M 26.40% 3.17M 3.17M OO Delaware 2021-11-12
9 Empery Asset Management, LP 1.79M 4.99% 1.79M PN Delaware 2018-01-12
10 Martin D. Hoe 1.79M 4.99% 1.79M IN United States 2018-01-12
11 Ryan M. Lane 1.79M 4.99% 1.79M IN United States 2018-01-12
12 Armistice Capital, LLC 965.8K 4.99% 965.8K 965.8K IA, OO Delaware 2017-06-23
13 Peter H. Kamin 782.0K 18.60% 782.0K 782.0K 11.00 IN 2022-02-01
14 Douglas M. Singer 293.0K 6.98% 293.0K 293.0K IN United States 2022-02-10
15 (. 1.7K 0.10% 1.7K 1.7K IA Delaware 2017-02-09
16 Jon M. Plexico 11.00% HC, IN U.S.A. 2021-02-12
17 Stonepine Capital Management, LLC 11.00% IA, OO California 2021-02-12
18 Stonepine Capital, L.P. 11.00% PN Delaware 2021-02-12
19 Timothy P. Lynch 11.00% HC, IN U.S.A. 2021-02-12
20 HEARTLAND ADVISORS, INC. 0.00% IA PERSON WITH 2017-01-10
21 William J. Nasgovitz 0.00% IN PERSON WITH 2017-01-10

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
25.0K
Shares disposed
Cash buys
Cash sales
Net activity
+25,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-01-20 Ampersand 2018 Limited Partnership 10% Owner C-Conversion A Common Stock 13,861,386 2.02 28.00M 13,861,386 D
2026-01-20 1315 Capital II, L.P. 10% Owner C-Conversion A Common Stock 9,405,941 2.02 19.00M 9,405,941 D
2024-12-01 McCarthy Christopher Officer M-Exempt A Common Stock 1,111 0.00 46,791 D
2024-10-11 Ampersand 2018 Limited Partnership 10% Owner D-Return A Series B Convertible Preferred Stock 28,000 6.00 168.0K 0 I
2024-10-11 1315 Capital II, L.P. 10% Owner A-Award A Series C Convertible Preferred Stock 19,000 2.02 38.4K 19,000 I
2024-07-27 McCarthy Christopher Officer M-Exempt A Common Stock 15,112 0.00 45,680 D
2024-02-01 McCarthy Christopher Officer M-Exempt A Common Stock 6,045 0.00 30,568 D
2024-01-31 McCarthy Christopher Officer M-Exempt A Common Stock 7,556 0.00 24,523 D
2023-12-01 McCarthy Christopher Officer M-Exempt A Common Stock 1,095 0.00 16,967 D
2023-07-31 McCarthy Christopher Officer A-Award A Common Stock 25,000 0.00 35,644
2023-04-21 McCarthy Christopher Officer D Restricted Stock Units 5,000 0.00 0
2022-02-01 AGGARWAL VIJAY Director A-Award A Stock Option (right to buy) 28,000 5.04 141.1K 28,000
2021-05-21 Burnell Thomas W. Director / Officer P-Purchase A Common Stock 10,855 8.68 94.2K 10,855
2021-03-10 Freeburg Thomas John Officer A-Award A Common Stock 50,000 0.00 52,000
2021-03-01 Kamin Peter 10% Owner P-Purchase A Common Stock 14,726 3.08 45.4K 234,805
2021-02-26 Kamin Peter 10% Owner P-Purchase A Common Stock 14,946 3.17 47.4K 253,748
2021-02-18 Kamin Peter 10% Owner D Common Stock 0 0.00 270,108
2021-01-29 Gorman Robert J. Director A-Award A Common Stock 12,438 4.02 50.0K 18,759
2020-12-01 STOVER JACK E Director / Officer A-Award A Stock option (right to buy) 43,750 6.00 262.5K 43,750
2020-12-01 Burnell Thomas W. Director / Officer A-Award A Common Stock 125,000 0.00 225,000
2020-07-29 Early James Officer M-Exempt A Common Stock 5,000 0.00 7,125
2020-07-09 SULLIVAN STEPHEN J Director A-Award A Stock Option (right to buy) 29,300 5.21 152.7K 29,300
2020-07-09 Rocca Fortunato R. Director A-Award A Stock Option (right to buy) 28,000 5.21 145.9K 28,000
2020-07-09 KEEGAN JOSEPH D Director A-Award A Stock Option (right to buy) 29,000 5.21 151.1K 29,000
2020-07-09 Gorman Robert J. Director A-Award A Stock Option (right to buy) 77,000 5.21 401.2K 77,000
2020-03-12 STOVER JACK E Director / Officer A-Award A Common Stock 7,188 0.00 30,271
2020-01-29 Knechtel Fred S. Officer A-Award A Stock Option (right to buy) 60,000 7.91 474.6K 60,000
2020-01-29 Gorman Robert J. Director A-Award A Common Stock 6,321 7.91 50.0K 6,321
2020-01-29 Early James Officer A-Award A Restricted Stock Units 5,000 0.00 5,000
2020-01-22 STOVER JACK E Director / Officer 0 0.00 0
2020-01-22 Rocca Fortunato R. Director 0 0.00 0
2020-01-22 Richard Gregory Officer 0 0.00 0
2020-01-15 McCarthy Laurence Director D-Return A Series A Convertible Preferred Stock 270 8.00 2.2K 0
2020-01-15 Lev Eric B. Director A-Award A Series B Convertible Preferred Stock 1,000 6.00 6.0K 28,000
2020-01-15 Chan Edward Director 0 0.00 0
2020-01-15 Ampersand 2018 Limited Partnership 10% Owner A-Award A Series B Convertible Preferred Stock 27,000 6.00 162.0K 27,000
2020-01-15 1315 Capital II, L.P. 10% Owner D Series B Convertible Preferred Stock 3,166,666 6.00 19.00M 0
2019-10-17 McCarthy Laurence Director I Series A Convertible Preferred Stock 33,750,000 0.80 27.00M 0
2019-10-17 Gorman Robert J. Director 0 0.00 0
2019-10-16 Lev Eric B. Director A-Award A Series A Convertible Preferred Stock 130 0.80 104.00 270
2019-10-16 Ampersand 2018 Limited Partnership 10% Owner A-Award A Series A Convertible Preferred Stock 130 0.80 104.00 270
2019-10-10 Lev Eric B. Director A-Award A Series A Convertible Preferred Stock 80 0.80 64.00 140
2019-10-10 Ampersand 2018 Limited Partnership 10% Owner A-Award A Series A Convertible Preferred Stock 80 0.80 64.00 140
2019-07-15 Lev Eric B. Director / 10% Owner I Series A Convertible Preferred Stock 7,500,000 0.80 6.00M 0
2019-07-15 Ampersand 2018 Limited Partnership 10% Owner I Series A Convertible Preferred Stock 7,500,000 0.80 6.00M 0
2019-03-13 STOVER JACK E Director / Officer A-Award A Stock Option (right to buy) 347,688 0.98 340.7K 347,688
2019-03-13 Richard Gregory Officer A-Award A Stock Option (right to buy) 158,112 0.98 154.9K 158,112
2019-03-13 Freeburg Thomas John Officer A-Award A Common Stock 2,000 0.00 2,000
2019-03-13 Early James Officer A-Award A Common Stock 26,340 0.00 43,340
2018-12-05 STOVER JACK E Director / Officer A-Award A Stock Option (right to buy) 348,000 1.08 375.8K 348,000
2018-12-05 Richard Gregory Officer A-Award A Stock Option (right to buy) 53,600 1.08 57.9K 53,600
2018-12-05 Early James Officer A-Award A Stock Option (right to buy) 15,000 1.08 16.2K 15,000
2018-03-07 Schnoll-Sussman Felice Director A-Award A Common Stock 4,800 0.00 4,800
2018-03-07 SULLIVAN STEPHEN J Director A-Award A Common Stock 4,800 0.00 24,583
2018-03-07 STOVER JACK E Director / Officer A-Award A Stock Option (right to buy) 224,000 1.01 226.2K 224,000
2018-03-07 Richard Gregory Officer A-Award A Common Stock 28,000 0.00 31,241
2018-03-07 KEEGAN JOSEPH D Director A-Award A Common Stock 4,800 0.00 17,569
2018-03-07 Freeburg Thomas John Officer 0 0.00 0
2018-03-07 Early James Officer A-Award A Common Stock 14,000 0.00 14,000
2018-02-26 Richard Gregory Officer M-Exempt A Common Stock 2,000 0.00 3,241
2017-09-26 STOVER JACK E Director / Officer A-Award A Stock Option (right to buy) 345,000 1.45 500.3K 345,000
2017-09-26 Richard Gregory Officer A-Award A Stock Option (right to buy) 200,000 1.45 290.0K 200,000
2017-09-26 Early James Officer A-Award A Stock Option (right to buy) 40,000 1.45 58.0K 40,000
2017-09-25 Schnoll-Sussman Felice Director A-Award A Stock Option (right to buy) 20,000 1.48 29.6K 20,000
2017-09-25 SULLIVAN STEPHEN J Director A-Award A Stock Option (right to buy) 13,000 1.48 19.2K 13,000
2017-09-25 KEEGAN JOSEPH D Director A-Award A Stock Option (right to buy) 10,000 1.48 14.8K 10,000
2017-09-14 Richard Gregory Officer D Stock Appreciation Right 3,742 45.70 171.0K 0
2017-09-12 Schnoll-Sussman Felice Director 0 0.00 0
2017-03-16 STOVER JACK E Director / Officer A-Award A Stock Option (right to buy) 134,602 2.12 285.4K 134,602
2017-03-16 Early James Officer A-Award A Stock Option (right to buy) 14,475 2.12 30.7K 14,475
2017-03-15 SULLIVAN STEPHEN J Director A-Award A Stock Option (right to buy) 13,000 2.18 28.3K 13,000
2017-03-15 KEEGAN JOSEPH D Director A-Award A Stock Option (right to buy) 10,000 2.18 21.8K 10,000
2016-10-14 STOVER JACK E Director / Officer A-Award A Stock Option (right to buy) 326,368 0.16 52.2K 326,368
2016-10-14 NASGOVITZ WILLIAM J 0 0.00 0
2016-10-14 Early James Officer A-Award A Stock Option (right to buy) 80,000 0.16 12.8K 80,000
2016-10-11 Early James Officer 0 0.00 0
2016-03-01 Krishnamurti Nat Officer A-Award A Restricted stock units 60,000 0.00 60,000
2016-02-03 SULLIVAN STEPHEN J Director A-Award A Common Stock 100,000 0.47 47.0K 197,828
2016-02-03 STOVER JACK E Director / Officer A-Award A Common Stock 100,000 0.53 53.0K 197,378
2016-02-03 KEEGAN JOSEPH D Director A-Award A Common Stock 127,696 0.47 60.0K 127,696
2016-02-03 Glorikian Harry Director A-Award A Common Stock 127,696 0.47 60.0K 127,696
2016-01-01 KEEGAN JOSEPH D Director 0 0.00 0
2016-01-01 Glorikian Harry Director 0 0.00 0
2015-12-28 Miao Graham G Officer F-InKind D Common Stock 69,020 0.53 36.6K 142,852
2015-12-01 Melillo Gerald R JR Officer S-Sale D Common Stock 1,748 0.77 1.3K 130,173
2015-11-30 Melillo Gerald R JR Officer S-Sale D Common Stock 765 0.80 612.00 131,921
2015-11-25 Melillo Gerald R JR Officer S-Sale D Common Stock 4,262 0.78 3.3K 132,686
2015-10-30 Ratnam Kapila Director 0 0.00 0
2015-06-03 SULLIVAN STEPHEN J Director A-Award A Common Stock 34,091 1.32 45.0K 97,828
2015-06-03 STOVER JACK E Director A-Award A Common Stock 34,091 1.32 45.0K 97,378
2015-06-03 FEDERSPIEL JOHN Director A-Award A Common Stock 34,091 1.32 45.0K 100,378
2015-06-03 Dreismann Heiner Director A-Award A Common Stock 34,091 1.32 45.0K 50,177
2015-06-03 Belle Gerald P. Director A-Award A Common Stock 45,455 1.32 60.0K 143,086
2015-04-28 NASGOVITZ WILLIAM J 10% Owner 0 0.00 0
2015-03-05 Lurker Nancy Director / Officer A-Award A Common Stock 444,364 1.73 768.7K 871,681
2015-02-24 Miao Graham G Officer A-Award A Common Stock 147,973 1.85 273.8K 211,872
2015-02-24 Melillo Gerald R JR Officer A-Award A Common Stock 91,217 1.85 168.8K 136,948
2014-11-25 Miao Graham G Officer P-Purchase A Common Stock 21,400 1.65 35.3K 63,899
2014-11-24 Miao Graham G Officer P-Purchase A Common Stock 600 1.65 990.00 42,499
2014-11-10 Lurker Nancy Director / Officer P-Purchase A Common Stock 16,000 1.69 27.1K 533,317
2014-11-07 Smith Jeffrey Edward Officer P-Purchase A Common Stock 200 1.50 300.00 467,194
2014-11-07 Melillo Gerald R JR Officer P-Purchase A Common Stock 5,000 1.58 7.9K 49,469
2014-11-07 Lurker Nancy Director / Officer P-Purchase A Common Stock 33,000 1.77 58.5K 517,317
2014-11-06 Lurker Nancy Director / Officer P-Purchase A Common Stock 1,000 1.60 1.6K 490,403
2014-11-05 Lurker Nancy Director / Officer P-Purchase A Common Stock 500 1.72 860.00 488,903
2014-11-05 Belle Gerald P. Director P-Purchase A Common Stock 57,300 1.71 98.1K 154,931
2014-10-20 Miao Graham G Officer A-Award A Stock Appreciation Rights 117,187 1.79 209.8K 117,187
2014-08-13 Dreismann Heiner Director A-Award A Common Stock 16,086 3.73 60.0K 16,086
2014-06-04 SULLIVAN STEPHEN J Director A-Award A Common Stock 9,956 4.52 45.0K 63,737
2014-06-04 STOVER JACK E Director A-Award A Common Stock 9,956 4.52 45.0K 63,287
2014-06-04 FEDERSPIEL JOHN Director A-Award A Common Stock 9,956 4.52 45.0K 66,287
2014-06-04 Climaco John M Director A-Award A Common Stock 9,956 4.52 45.0K 21,539
2014-06-04 Belle Gerald P. Director A-Award A Common Stock 13,274 4.52 60.0K 97,631
2014-03-25 Lurker Nancy Officer F-InKind D Common Stock 23,316 4.91 114.5K 433,403
2014-02-26 Lurker Nancy Officer A-Award A Stock Appreciation Rights 177,665 5.10 906.1K 489,951
2014-02-25 Smith Jeffrey Edward Officer A-Award A Common Stock 31,532 5.13 161.8K 267,194
2014-02-25 Melillo Gerald R JR Officer A-Award A Stock Appreciation Rights 57,107 5.13 293.0K 108,949
2013-11-18 Belle Gerald P. Director P-Purchase A Common Stock 13,000 5.25 68.3K 84,357
2013-11-15 Belle Gerald P. Director P-Purchase A Common stock 7,400 5.14 38.0K 71,357
2013-10-29 Climaco John M Director A-Award A Common Stock 11,583 5.18 60.0K 11,583
2013-06-04 SULLIVAN STEPHEN J Director A-Award A Common Stock 10,068 4.47 45.0K 53,781
2013-06-04 STOVER JACK E Director A-Award A Common Stock 10,068 4.47 45.0K 53,331
2013-06-04 LUBATKIN VERONICA Director A-Award A Common Stock 10,068 4.47 45.0K 54,137
2013-06-04 FEDERSPIEL JOHN Director A-Award A Common Stock 10,068 4.47 45.0K 56,331
2013-06-04 Belle Gerald P. Director A-Award A Common Stock 13,423 4.47 60.0K 63,957
2013-04-04 Smith Jeffrey Edward Officer A-Award A Common Stock 25,660 5.44 139.6K 231,441
2013-04-04 Melillo Gerald R JR Officer A-Award A Common Stock 10,997 5.44 59.8K 24,424
2013-04-04 Lurker Nancy Officer A-Award A Common Stock 51,320 5.44 279.2K 382,958
2013-03-01 Smith Jeffrey Edward Officer F-InKind D Common Stock 7,310 7.43 54.3K 205,781
2013-03-01 Saitta Jo Ann Officer F-InKind D Common Stock 4,642 7.43 34.5K 52,601
2013-03-01 Lurker Nancy Officer F-InKind D Common Stock 16,279 7.43 121.0K 331,638
2012-12-21 Saitta Jo Ann Officer F-InKind D Common Stock 276 7.81 2.2K 57,243
2012-06-05 SULLIVAN STEPHEN J Director A-Award A Common Stock 5,577 8.07 45.0K 43,713
2012-06-05 STOVER JACK E Director A-Award A Common Stock 5,577 8.07 45.0K 43,263
2012-06-05 LUBATKIN VERONICA Director A-Award A Common Stock 5,577 8.07 45.0K 44,069
2012-06-05 FEDERSPIEL JOHN Director A-Award A Common Stock 5,577 8.07 45.0K 46,263
2012-06-05 Belle Gerald P. Director A-Award A Common Stock 7,435 8.07 60.0K 50,534
2012-02-21 Smith Jeffrey Edward Officer F-InKind D Common Stock 6,367 7.00 44.6K 213,091
2012-02-21 Saitta Jo Ann Officer F-InKind D Common Stock 2,877 7.00 20.1K 57,519
2012-01-31 Saitta Jo Ann Officer D Stock Appreciation Rights 25,773 6.63 170.9K 0
2012-01-31 Lurker Nancy Officer A-Award A Common Stock 50,702 6.41 325.0K 347,917
2012-01-30 Smith Jeffrey Edward Officer A-Award A Common Stock 22,624 6.63 150.0K 219,458
2012-01-30 Melillo Gerald R JR Officer A-Award A Stock Appreciation Rights 21,478 6.63 142.4K 21,478
2011-10-10 Melillo Gerald R JR Officer A-Award A Common Stock 4,000 6.59 26.4K 4,000
2011-05-31 SULLIVAN STEPHEN J Director A-Award A Common Stock 6,522 6.90 45.0K 38,136
2011-05-31 STOVER JACK E Director A-Award A Common Stock 6,522 6.90 45.0K 37,686
2011-05-31 RYAN FRANK J Director A-Award A Common Stock 6,522 6.90 45.0K 43,686
2011-05-31 LUBATKIN VERONICA Director A-Award A Common Stock 6,522 6.90 45.0K 38,492
2011-05-31 FEDERSPIEL JOHN Director A-Award A Common Stock 6,522 6.90 45.0K 40,686
2011-05-31 Belle Gerald P. Director A-Award A Common Stock 8,696 6.90 60.0K 43,099
2011-03-15 Lurker Nancy Officer M-Exempt A Common Stock 11,472 8.24 94.5K 297,215
2011-03-03 Smith Jeffrey Edward Officer A-Award A Common Stock 41,469 8.44 350.0K 196,834
2011-03-03 Micali Richard P Officer A-Award A Common Stock 17,773 8.44 150.0K 36,754
2011-03-03 Lurker Nancy Officer A-Award A Common Stock 82,938 8.44 700.0K 285,743
2011-03-03 Kerr David E Officer A-Award A Common Stock 17,773 8.44 150.0K 28,771
2010-12-23 Micali Richard P Officer F-InKind D Common Stock 224 10.98 2.5K 18,981
2010-12-23 Kerr David E Officer F-InKind D Common Stock 225 10.98 2.5K 10,998
2010-12-21 Smith Jeffrey Edward Officer A-Award A Common Stock 4,554 10.98 50.0K 155,365
2010-12-21 Micali Richard P Officer A-Award A Common Stock 2,277 10.98 25.0K 19,205
2010-12-21 Lurker Nancy Officer A-Award A Common Stock 9,107 10.98 100.0K 202,805
2010-12-21 Kerr David E Officer A-Award A Common Stock 2,277 10.98 25.0K 11,223
2010-11-29 Drazner Howard Officer F-InKind D Common Stock 491 9.66 4.7K 26,379
2010-11-18 Belle Gerald P. Director P-Purchase A Common Stock 1,000 10.60 10.6K 34,403
2010-11-16 Drazner Howard Officer M-Exempt D Stock Appreciation Rights 5,273 5.89 31.1K 26,474
2010-11-03 Likoff Robert Owen Officer 0 0.00 0
2010-11-03 Davis Jack Officer 0 0.00 0
2010-06-03 VECSI JAN MARTENS Director A-Award A Common Stock 5,689 7.91 45.0K 46,764
2010-06-03 SULLIVAN STEPHEN J Director A-Award A Common Stock 5,689 7.91 45.0K 31,614
2010-06-03 STOVER JACK E Director A-Award A Common Stock 5,689 7.91 45.0K 31,164
2010-06-03 RYAN FRANK J Director A-Award A Common Stock 5,689 7.91 45.0K 37,164
2010-06-03 LUBATKIN VERONICA Director A-Award A Common Stock 5,689 7.91 45.0K 31,970
2010-06-03 FEDERSPIEL JOHN Director A-Award A Common Stock 5,689 7.91 45.0K 34,164
2010-06-03 Belle Gerald P. Director A-Award A Common Stock 7,585 7.91 60.0K 33,403
2010-03-01 Smith Jeffrey Edward Officer A-Award A Stock Apprecation Rights 38,153 5.03 191.9K 137,175
2010-03-01 Micali Richard P Officer A-Award A Stock Appreciation Rights 24,096 5.03 121.2K 27,096
2010-03-01 Lurker Nancy Officer A-Award A Common Stock 43,738 5.03 220.0K 193,698
2010-03-01 Kerr David E Officer A-Award A Stock Appreciation Rights 18,072 5.03 90.9K 43,072
2010-03-01 Drazner Howard Officer A-Award A Stock Appreciation Rights 10,040 5.03 50.5K 43,750
2009-08-21 Smith Jeffrey Edward Officer P-Purchase A Common Stock 2,500 5.25 13.1K 131,924
2009-08-18 Lurker Nancy Officer P-Purchase A Common Stock 6,000 5.17 31.0K 149,960
2009-08-17 Lurker Nancy Officer P-Purchase A Common Stock 3,960 5.05 20.0K 143,960
2009-08-11 Belle Gerald P. Director P-Purchase A Common Stock 1,000 5.21 5.2K 25,818
2009-06-04 VECSI JAN MARTENS Director A-Award A Common Stock 12,262 3.67 45.0K 41,075
2009-06-04 SULLIVAN STEPHEN J Director A-Award A Common Stock 12,262 3.67 45.0K 25,925
2009-06-04 STOVER JACK E Director A-Award A Common Stock 12,262 3.67 45.0K 25,475
2009-06-04 RYAN FRANK J Director A-Award A Common Stock 12,262 3.67 45.0K 31,475
2009-06-04 PIETRUSKI JOHN M Director A-Award A Common Stock 12,262 3.67 45.0K 27,475
2009-06-04 LUBATKIN VERONICA Director A-Award A Common Stock 12,262 3.67 45.0K 26,281
2009-06-04 FEDERSPIEL JOHN Director A-Award A Common Stock 12,262 3.67 45.0K 28,475
2009-06-04 CURTI JOSEPH I Director A-Award A Common Stock 12,262 3.67 45.0K 25,475
2009-06-04 Belle Gerald P. Director A-Award A Common Stock 12,262 3.67 45.0K 24,818
2009-06-03 Kerr David E Officer D Stock Appreciation Rights 25,000 3.32 83.0K 0
2009-05-14 VECSI JAN MARTENS Director P-Purchase A Common Stock 1,500 3.47 5.2K 28,813
2009-04-01 Tilles Peter Officer D Stock Appreciation Rights 9,101 7.73 70.4K 0
2009-04-01 Micali Richard P Officer D Stock Appreciation Rights 3,000 4.56 13.7K 0
2009-04-01 Drazner Howard Officer D Stock Appreciation Rights 5,936 9.52 56.5K 0
2009-02-19 Smith Jeffrey Edward Officer A-Award A Stock Appreciation Rights 41,527 5.89 244.6K 99,022
2008-12-02 Smith Jeffrey Edward Officer P-Purchase A Common Stock 50,000 4.00 200.0K 111,597
2008-11-26 RYAN FRANK J Director P-Purchase A Common Stock 6,000 4.00 24.0K 13,658
2008-11-24 VECSI JAN MARTENS Director P-Purchase A Common Stock 900 3.63 3.3K 9,158

Executive team

Top executives
EBIT / Employee
35.5K
Shares Outstanding
4.42M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2017 CEO 318.5K 92.0K 696.0K 937.1K 12.9K 2.06M 33.84%
2 2017 Chief Commercial Officer 266.3K 100.0K 399.1K 18.4K 783.8K 50.92%
3 2017 CFO 535.3K 69.9K 605.2K 11.55%
4 2016 CEO 296.7K 127.5K 29.0K 50.7K 1.0K 552.3K 5.25%
5 2016 Chief Commercial Officer 246.0K 70.0K 13.8K 17.8K 5.0K 16.7K 369.3K 8.55%
6 2016 Former CFO 71.6K 166.0K 237.7K 0.00%
7 2016 CFO 116.5K 123.3K 0.00%
8 2015 Former CFO 420.0K 273.8K 693.8K 39.46%
9 2015 CEO 8.1K 108.2K 116.3K 0.00%
10 2007 CEO 411.3K 158.4K 94.4K 280.0K 28.0K 972.2K 26.01%
11 2007 EVP, CFO and Treasurer 306.4K 119.7K 54.0K 191.0K 27.5K 698.5K 24.86%
12 2007 Former President 87.5K 29.4K 576.0K 652.2K 4.51%
13 2007 EVP and President, DMS 274.8K 80.4K 27.9K 77.0K 25.8K 485.9K 22.29%
14 2007 EVP, Human Resources 198.2K 64.0K 17.8K 113.0K 25.8K 418.7K 19.52%
15 2006 Former President 322.1K 270.4K 22.0K 181.2K 21.1K 816.7K 35.81%
16 2006 Steven Budd - Former President 322.1K 270.4K 22.0K 181.2K 21.1K 816.7K 35.81%
17 2006 CEO 254.6K 31.2K 160.0K 140.8K 619.4K 5.04%
18 2006 Michael Marquard - Chief Executive Officer 254.6K 31.2K 32.7K 160.0K 140.8K 619.4K 10.33%
19 2006 EVP and President, DMS 267.3K 66.8K 11.0K 168.4K 18.2K 531.6K 14.63%
20 2006 EVP, Human Resources 212.7K 50.0K 57.4K 11.0K 143.6K 18.3K 492.9K 13.87%
21 2006 Jeffrey Smith - EVP,Chief Financial Officer and Treasurer 188.7K 20.8K 21.9K 133.7K 7.7K 372.8K 11.47%
22 2006 EVP, CFO and Treasurer 188.7K 20.8K 21.9K 133.7K 7.7K 372.8K 11.47%
23 2006 SUMMARY COMPENSATION TABLE FOR 2006 Name and Principal Position 2.0K 2.0K 2.0K 2.0K 2.0K 2.0K 200.00%
24 2005 Charles Saldarini Former Vice Chairman and CEO 385.4K 34.7K 2.36M 2.74M 1.26%
25 2005 Bernard Boyle Former CFO, Executive VP and Treasurer 280.4K 477.9K 500.1K 8.5K 1.44M 2.70M 18.83%
26 2005 Steven Budd President 313.5K 753.0K 1.00M 10.6K 8.2K 2.07M 48.71%
27 2005 Stephen Cotugno Executive VP - Corporate Development and Investor Relations 225.6K 394.9K 266.7K 3.8K 887.2K 30.49%
28 2005 Nancy McCarthy Executive VP - Human Resources 202.8K 254.4K 166.7K 3.4K 624.0K 27.26%
29 2005 Larry Ellberger Interim CEO 113.7K 7.5K 203.3K 317.0K 2.37%
30 2005 Alan Rubino Former Executive VP and General Manager - Sales Team business 67.1K 249.8K 5.3K 316.8K 1.67%
31 2005 Beth Jacobson Former Executive VP, General Counsel and Corp orate Secretary 223.2K 3.4K 223.2K 1.52%
32 2004 Beth Jacobson Former Executive VP, General Counsel and Corp orate Secretary 220.0K 26.2K 420.7K 667.0K 0.00%
33 2004 Nancy McCarthy Executive VP - Human Resources 106.1K 10.0K 430.3K 536.4K 1.86%
34 2004 Charles Saldarini Former Vice Chairman and CEO 432.0K 150.0K 432.0K 34.72%
35 2004 Steven Budd President 308.5K 75.0K 308.5K 24.31%
36 2004 Bernard Boyle Former CFO, Executive VP and Treasurer 275.8K 40.0K 5.8K 281.6K 14.20%
37 2004 Alan Rubino Former Executive VP and General Manager - Sales Team business 228.3K 10.0K 228.3K 4.38%
38 2004 Stephen Cotugno Executive VP - Corporate Development and Investor Relations 221.1K 25.0K 600.00 221.7K 11.28%
39 2004 Larry Ellberger Interim CEO 7.5K 55.0K 55.0K 13.64%
40 2003 Charles Saldarini Former Vice Chairman and CEO 376.5K 277.1K 653.6K 0.00%
41 2003 Steven Budd President 289.6K 209.0K 498.6K 0.00%
42 2003 Bernard Boyle Former CFO, Executive VP and Treasurer 263.3K 194.6K 457.9K 0.00%
43 2003 Stephen Cotugno Executive VP - Corporate Development and Investor Relations 188.5K 143.1K 331.6K 0.00%
44 2003 Beth Jacobson Former Executive VP, General Counsel and Corp orate Secretary 185.0K 130.7K 315.7K 0.00%
45 2003 Alan Rubino Former Executive VP and General Manager - Sales Team business 184.4K 184.4K 0.00%
46 2003 Nancy McCarthy Executive VP - Human Resources 99.8K 99.8K 0.00%
47 2003 Larry Ellberger Interim CEO 17.5K 40.6K 40.6K 43.08%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2024-09-20 DEFA14A
2024-09-20 DEF 14A
2023-09-22 DEFA14A
2023-09-22 DEF 14A
2022-09-20 DEFA14A
2022-09-20 DEF 14A
2022-09-09 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-30 10-K/A
2026-04-01 8-K
2026-03-30 10-K
2026-02-17 4
2026-02-04 4
2026-01-20 8-K
2025-12-03 8-K
2025-11-12 8-K
2025-11-12 10-Q
2025-08-08 8-K

Executive team

NameTitleCompensationGender
Thomas W. Burnell President, Chief Executive Officer & Chairman 708.2K
Christopher McCarthy Chief Financial Officer & Chief Operating Officer 468.3K male
Nicole Massoll Chief Medical Officer
Patrick Kane Vice President & Corporate Controller male
Sydney D. Finkelstein Chief Scientific Officer
ESG Rating
B-
MEDICAL - DIAGNOSTICS & RESEARCH
Rank: 44 out of 58
2013
E (Environmental)
86.8 / 61.3
Company / Sector avg.
S (Social)
76.2 / 65.4
Company / Sector avg.
G (Governance)
75.2 / 64.9
Company / Sector avg.
ESG Total
79.4 / 63.8
Company / Sector avg.
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits